Published on 9 May 2024 on Insider Monkey via Yahoo Finance
Arcus Biosciences, Inc. (NYSE:RCUS) Q1 2024 Earnings Call Transcript
Arcus Biosciences, Inc. (NYSE:RCUS) Q1 2024 Earnings Call Transcript May 8, 2024
Arcus Biosciences, Inc. beats earnings expectations. Reported EPS is $-0.05, expectations were $-0.97. Arcus Biosciences, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).
Operator: Hello, all and welcome to Arcus Biosciences First Quarter 2024 Earnings Call. My name is Lydia, and I’ll be your operator today. [Operator Instructions] I’ll now hand you over to Pia Eaves, Vice President of Investor Relations & Strategy.